Zobrazeno 1 - 10
of 14
pro vyhledávání: '"S A, Chorbinskaya"'
Autor:
E. L. Nasonov, N. N. Yakhno, A. E. Karateev, L. I. Alekseeva, A. N. Barinov, A. E. Barulin, O. S. Davydov, A. B. Danilov, M. V. Zhuravleva, B. V. Zavodovsky, S. S. Kopenkin, M. L. Kukishkin, V. A. Parfenov, M. A. Strakhov, V. P. Tyurin, N. V. Chichasova, S. A. Chorbinskaya
Publikováno v:
Научно-практическая ревматология, Vol 54, Iss 3, Pp 247-265 (2016)
The main manifestation of joint and spine diseases, such as osteoarthritis, nonspecific back pain, and soft tissue rheumatic disorders, is musculoskeletal pain (MSP). It leads to considerable morbidity as well as temporary and permanent disability in
Externí odkaz:
https://doaj.org/article/59a34fdb9e0740fabc774b0c877bc357
Autor:
M A, Samushiya, S M, Kryzhanovsky, A A, Ragimova, T Z, Berishvili, S A, Chorbinskaya, E I, Ivannikova
Publikováno v:
Neuroscience and Behavioral Physiology. 52:231-235
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f493a636d787d1b8961ea830ceb08b3
https://doi.org/10.1007/s11055-022-01229-z
https://doi.org/10.1007/s11055-022-01229-z
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 3, Pp 62-66 (2015)
Retracted 11.11.2019To reduce the overall cardiovascular risk it is advisable to use a combination of drugs - the poly-pill that will increase the effectiveness of therapy and patient compliance. The company «Gedeon Richter» has created a polypill
Externí odkaz:
https://doaj.org/article/b08be7e0d21f40dd8af620b70c28eb6c
Publikováno v:
КардиоСоматика, Vol 6, Iss 1, Pp 76-82 (2015)
The article deals with the use of calcium antagonists (CA) with a focus on diltiazem for the treatment of hypertension, angina pectoris, and cardiac arrhythmias, for secondary prevention of coronary heart disease, to evaluate their cardiac, angiograp
Externí odkaz:
https://doaj.org/article/fd50505bfcc144658e0bf76e86be9d62
Publikováno v:
КардиоСоматика, Vol 5, Iss 1, Pp 9-15 (2014)
The article presents the results of studies on the effectiveness and safety of a III generation calcium antagonist lercanidipine in the treatment of hypertension. Lercanidipine treatment leads to a marked significant reduction in systolic and diastol
Externí odkaz:
https://doaj.org/article/3606a8aab4434649b35f5d670f4c9a2a
Publikováno v:
Effective Pharmacotherapy. :54-60
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64c089a0630c047bad78fdd59b3c860c
https://doi.org/10.33978/2307-3586-2019-15-20-54-60
https://doi.org/10.33978/2307-3586-2019-15-20-54-60
Publikováno v:
Consilium Medicum. 20:65-71
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14e2a14febf76c59b6488b536ec39c26
https://doi.org/10.26442/2075-1753_2018.10.65-71
https://doi.org/10.26442/2075-1753_2018.10.65-71
Autor:
S A Chorbinskaya, T Z Berishvili, E I Ivannikova, M A Samushiya, S M Kryzhanovsky, A A Ragimova
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 121:49
To study the prevalence of anxiety-depressive disorders and sleep disorders in their structure among patients hospitalized in connection with COVID-19, as well as to develop differentiated recommendations for their therapy in patients with new corona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbb230f8d9271c5d4bc0f8949dfd04b7
https://doi.org/10.17116/jnevro202112104249
https://doi.org/10.17116/jnevro202112104249
Publikováno v:
Meditsina truda i promyshlennaia ekologiia. (11)
The study was aimed to evaluate treatment efficiency of patients with chronic cardiac failure via therapeutic teaching. The study included 137 patients. Implementation of therapeutic teaching into treatment of chronic cardiac failure patients resulte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0eb4414526f2ddc68dbe5c5461eb6a42
https://pubmed.ncbi.nlm.nih.gov/30351687
https://pubmed.ncbi.nlm.nih.gov/30351687
Publikováno v:
КардиоСоматика, Vol 6, Iss 1, Pp 76-82 (2015)
The article deals with the use of calcium antagonists (CA) with a focus on diltiazem for the treatment of hypertension, angina pectoris, and cardiac arrhythmias, for secondary prevention of coronary heart disease, to evaluate their cardiac, angiograp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dafba5d56780175ec8526f8dbea121d5
https://cardiosomatics.orscience.ru/2221-7185/article/view/45175
https://cardiosomatics.orscience.ru/2221-7185/article/view/45175